"I shall take the first dose of COVID vaccine if people have a trust deficit," says Harsh Vardhan
Union Health and Family Welfare Minister Harsh Vardhan participating in an interaction with his social media followers on the Sunday Samvad platform, in New Delhi on September 13, 2020

"I shall take the first dose of COVID vaccine if people have a trust deficit," says Harsh Vardhan

New Delhi, September 13, 2020

Union Health & Family Welfare Minister Harsh Vardhan today said that he would be happy to take the first dose of the novel coronavirus (COVID-19) vaccine to allay fears about its safety.

“I shall be the first to offer myself for receiving COVID vaccine, if people have a trust deficit about its safety aspects," Dr Harsh Vardhan said during an interaction with his social media followers on the Sunday Samvad platform.

The questions asked by the followers covered not only the current situation of COVID but also the government’s approach to it, the likely changes in the post-COVID world and the steps taken by government in its facilitation.

The Minister said that while no date has been fixed for the launch of the vaccine, it may be ready by the first quarter of 2021.

Dr Harsh Vardhan stated that the Government is taking full precautions in conducting the human trials of the vaccine and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr. V K Paul, Member (Health), NITI Aayog is drawing up a detailed strategy on how to immunize a majority of the population.

“Issues like vaccine security, cost, equity, cold-chain requirements, production timelines etc., are also being discussed intensely," he said.

He assured the people that the vaccine would be first made available to those who need it the most, irrespective of their paying capacity.

Further, he said that the Government is considering emergency authorization of COVID-19 vaccination especially in the case of senior citizens and people working in high-risk settings. “This shall be done after a consensus has been reached," he said.

On the vaccine candidates and their development in India, he said that Department of Biotechnology (DBT) as well as Indian Council of Medical Research (ICMR) have been pro-active in responding to the emerging situation to support advancement of vaccine candidates.

India is actively partnering with Coalition for Epidemic Preparedness Innovations (CEPI) and trials in different phases are going on with respect to several vaccines in Indian laboratories (private and public) and hospitals.

The Minister said that a safe and effective vaccine would help in establishing immunity to COVID-19 at a much faster pace as compared to the natural infection. It is hoped that a consensus will emerge in next few months over the desired level of protective herd immunity in any community, he stated.

Dr. Harsh Vardhan highlighted how the pandemic became a turning point for Indian manufacturing. From the time when there were “no indigenous manufacturers of PPEs with requisite standards, now there are nearly 110 indigenous manufacturers."

"The country is in a position to not only meet its own demands but also export to help out fellow nations," he said.

He said similar "Make in India" initiatives were launched and promoted for enhancing indigenous manufacturing of diagnostic kits, ventilators, drugs like Remdesivir etc., and reducing reliance on foreign countries. This was made possible through the "Whole of Government" approach under the leadership of Prime Minister Narendra Modi.

A multipronged strategy of promoting indigenous manufacturers and ensuring market availability was adopted with the partnership of various Ministries. He added that the Government took a number of initiatives to promote domestic manufacturing of critical APIs in India and thereby decrease India's dependence on imports of such APIs.

In order to make the healthcare cost reasonable and affordable for the common man, Dr. Harsh Vardhan said that the Government has directed all States and UTs to fix a reasonable price for COVID-19 treatment in private hospitals. Free coverage up to Rs 5 lakh for COVID patients for those who are eligible under the Ayushman Bharat PMJAY package was announced. He added that the Central Government has also asked States/UTs to proactively engage with the private sector health providers and consider pooling in public and private healthcare facilities, as this will help in providing prompt, good quality and reasonable health care to COVID-19 patients. He has himself appealed to the private hospitals to refrain from overcharging COVID patients, he stated.

The Minister said that measures had been taken to ensure accessibility and affordability of all drugs and other therapeutics to all citizens, irrespective of their paying capacities. The Government has taken cognizance of reports of alleged blackmarketing of drugs like Remdesivir and has asked Central Drugs Standard Control Organisation (CDSCO) to take suitable action against the same along with their State counterparts.

He stated that the Government is seized of the evolving nature of the infection and emerging evidence of the systemic health complications in those who have been infected. AIIMS and other research institutions have been asked to undertake research to study the long-term impact of COVID. ICMR is establishing a National Clinical Registry on COVID that will provide insights into the clinical course of COVID-19 disease, its spectrum and outcome of patients. Expert group consultations are already going on to review the emerging evidence and generate data on organ system-specific (respiratory system, renal system, cardiovascular and gastro-intestinal) sequelae of COVID, he stated.


Related Stories

No stories found.

Latest Stories

No stories found.

Trending Stories

No stories found.